Dillon Li

Proud to review clinical evidence, ongoing trials and biological rationale for local ablative therapy in #oligomet #NSCLC with thought leaders @danielrgomez44 and @IyengarPuneeth. Looking forward to upcoming phase 3 trial results! doi.org/10.1016/j.semr…

Our new study on nasopharyngeal cancer (NPC): proton therapy with IMPT for localized NPC is associated with fewer acute toxicities compared to standard of care IMRT, with local control rate of 100% at 2 years. @imrtlee @AnnaLeeMDMPH @MSK_RadOnc jamanetwork.com/journals/jaman…

@icm2uk @MandyBrasherMD I was literally chanting cremasters!